Loading...
Rising FDA And Payer Pressures Will Limit Market Traction
AnalystLowTarget's Fair Value
US$19.00
19.1% overvalued intrinsic discount04 Sep
US$22.63
1Y
-18.4%7D
-2.4%1Y
-18.4%7D
-2.4%You can edit this narrative until Aug 27 10:13 PM. Then, changes will post as Updates.